HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

15- deoxy- (16- m- tolyl)- 17,18,19,20- tetranorisocarbacyclin methylester

a prostacyclin receptor ligand

Also Known As:

15-deoxy-TIC-Me

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Lipids: 114793
- Fatty Acids: 27405
  - Unsaturated Fatty Acids: 8236
    - Eicosanoids: 3262
      - Prostaglandins: 17100
        Prostaglandins I: 108
        Epoprostenol: 4670
        15-deoxy-(16-m-tolyl)-17,18,19,20-tetranorisocarbacyclin methylester: 1
Biological Factors: 2472
- Inflammation Mediators: 1113
  - Autacoids: 276
    - Eicosanoids: 3262
      - Prostaglandins: 17100
        Prostaglandins I: 108
        Epoprostenol: 4670
        15-deoxy-(16-m-tolyl)-17,18,19,20-tetranorisocarbacyclin methylester: 1

Experts

1.	Cui, Yilong: 1 article (01/2002)
2.	Hosoya, Takamitsu: 1 article (01/2002)
3.	Kataoka, Yosky: 1 article (01/2002)
4.	Suzuki, Masaaki: 1 article (01/2002)
5.	Takamatsu, Hiroyuki: 1 article (01/2002)
6.	Tsukada, Hideo: 1 article (01/2002)
7.	Watanabe, Yasuyoshi: 1 article (01/2002)
8.	Watanabe, Yumiko: 1 article (01/2002)

Related Diseases

1.	Ischemia 01/25/2002 - "A selective central type prostacyclin receptor ligand, 15-deoxy-(16-m-tolyl)-17,18,19,20-tetranorisocarbacyclin methylester, or a peripheral type prostacyclin receptor ligand, iloprost methylester, were administered intravenously immediately after ischemia. "

Related Drugs and Biologics

1.	Epoprostenol Receptors
2.	Iloprost (Ventavis)
3.	Ligands